Actavis' Colitis Drug ANDA Triggers Patent Suit
Cosmo Technologies Ltd. and a Salix Pharmaceuticals Ltd. subsidiary have sued in New Jersey federal court to block Actavis Inc.'s abbreviated new drug application for a generic version of the colitis...To view the full article, register now.
Already a subscriber? Click here to view full article